PREDICTING REFRACTORY CANCER PAIN USING MACHINE LEARNING INTEGRATION OF CLINICAL, IMAGING, GENOMIC, AND OPIOID-RESPONSE PROFILES. Spect. Res. Rev. 2026, 4 (1), 1-18.